van de Schoot Agustinus J A J, van den Wollenberg Wouter, Carbaat Casper, de Ruiter Peter, Nowee Marlies E, Pos Floris, van Triest Baukelien, Sonke Jan-Jakob, Janssen Tomas M
Department of Radiation Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Phys Imaging Radiat Oncol. 2019 Apr 24;10:19-24. doi: 10.1016/j.phro.2019.04.004. eCollection 2019 Apr.
BACKGROUND & PURPOSE: Clinical introduction of magnetic resonance (MR)-guided radiotherapy involves treatment planning while taking into account machine-specific characteristics. Our aim was to investigate the feasibility of high-quality MR-linac treatment planning for an MR-linac and to benchmark MR-linac plan quality (IMRT) against current clinical practice (VMAT).
MATERIALS & METHODS: Data of eight rectal and eight prostate cancer patients, who received radiotherapy on a conventional CBCT-integrated linac, were selected. Clinically acquired CTs and associated delineations of target volumes and organs-at-risk (OARs) were used for MR-linac treatment planning in Monaco. To investigate treatment planning software bias 'quasi MR-linac plans' were generated in Pinnacle by mimicking MR-linac specific beam characteristics. MR-linac, quasi MR-linac, and clinical plans were compared and differences in target and OAR doses assessed. Differences in plan complexity were determined by the number of segments and monitor units.
Compared to clinical plans, MR-linac plans showed a statistically significant decrease in plan homogeneity, an increase in PTV D (prostate: 0.6 Gy; rectum: 0.8 Gy) and D (prostate: 1.9 Gy; rectum: 2.0 Gy), and increases in OAR dose. Quasi MR-linac plans were comparable to MR-linac plans with respect to OAR dose and plan homogeneity. For rectal cancer an increase was seen in PTV D (0.12 Gy) and D (0.5 Gy) compared to regular MR-linac plans. All created plans were clinically equivalent to current clinical practice.
This study demonstrates the feasibility of creating high-quality MR-linac treatment plans. The results supported the clinical introduction of an MR-linac.
磁共振(MR)引导放疗的临床应用涉及在考虑机器特定特性的同时进行治疗计划制定。我们的目的是研究为MR直线加速器制定高质量MR直线加速器治疗计划的可行性,并将MR直线加速器计划质量(调强放疗)与当前临床实践(容积调强弧形放疗)进行对比。
选取了8例直肠癌患者和8例前列腺癌患者的数据,这些患者在传统的CBCT集成直线加速器上接受了放疗。临床获取的CT图像以及靶区和危及器官(OAR)的相关轮廓用于在Monaco中进行MR直线加速器治疗计划制定。为了研究治疗计划软件偏差,在Pinnacle中通过模拟MR直线加速器的特定射束特性生成了“准MR直线加速器计划”。比较了MR直线加速器计划、准MR直线加速器计划和临床计划,并评估了靶区和OAR剂量的差异。通过射野分段数和监测单位确定计划复杂性的差异。
与临床计划相比,MR直线加速器计划在计划均匀性方面有统计学意义的降低,靶区平均剂量(前列腺:0.6 Gy;直肠:0.8 Gy)和处方剂量(前列腺:1.9 Gy;直肠:2.0 Gy)增加,OAR剂量增加。准MR直线加速器计划在OAR剂量和计划均匀性方面与MR直线加速器计划相当。对于直肠癌,与常规MR直线加速器计划相比,靶区平均剂量增加了0.12 Gy,处方剂量增加了0.5 Gy。所有生成的计划在临床上与当前临床实践等效。
本研究证明了制定高质量MR直线加速器治疗计划的可行性。结果支持了MR直线加速器的临床应用。